Status:
UNKNOWN
Pneumatic Displacement of Subretinal Hemorrhage With Perfluorocarbon Gases
Lead Sponsor:
Weill Medical College of Cornell University
Collaborating Sponsors:
The Edward Grayson Fund for Retinal Research
Conditions:
Subretinal Hemorrhage and Exudative Maculopathy
Eligibility:
All Genders
20-95 years
Phase:
PHASE2
Brief Summary
Subretinal hemorrhage in the macula causes a significant loss of vision. This hemorrhage can be displaced by the use of a small volume of pure perfluorocarbon gas injected into the vitreous, which exp...
Detailed Description
This protocol was designed to determine the optimum position of the gaze for pneumatic displacement of subretinal hemorrhage (SRH) in the macula. A geometrical analysis of the forces that act upon a S...
Eligibility Criteria
Inclusion
- Diminished vision secondary to subretinal hemorrhage in the macula or exudative maculopathy.
Exclusion
- Patient unable to maintain gaze position for 20 minutes every waking hour for 7 days.
- Patient unable to sleep on their side or with head elevated 40 degrees.
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00161525
Start Date
October 1 2003
End Date
June 1 2009
Last Update
January 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Presbyterian Hospital
New York, New York, United States, 10021